(PG) Procter & Gamble - NYSE
Sector: Consumer Defensive | Industry: Household & Personal Products | Exchange: NYSE (USA) | Market Cap: 345.424m USD | Total Return: -4.3% in 12m
Avg Turnover: 1.17B
EPS Trend: 91.6%
Qual. Beats: 0
Rev. Trend: 87.3%
Qual. Beats: 1
Warnings
No concerns identified
Tailwinds
No distinct edge detected
The Procter & Gamble Company (PG) is a global leader in the consumer packaged goods industry, operating a diverse portfolio across five primary segments: Beauty, Grooming, Health Care, Fabric & Home Care, and Baby, Feminine & Family Care. Founded in 1837 and headquartered in Cincinnati, Ohio, the company owns several multi-billion dollar brands including Tide, Gillette, Pampers, and Crest. Its distribution network spans traditional retail channels, e-commerce, and direct-to-consumer platforms.
The household products sector is characterized by high barriers to entry due to the significant capital required for global supply chains and large-scale marketing budgets. P&G utilizes a brand-management business model that focuses on organic innovation and premiumization to maintain market share against private-label competitors. Investors looking for deeper fundamental analysis may find further value in reviewing the data on ValueRay. This stability-oriented model often allows the company to maintain consistent performance across various economic cycles.
- Premium pricing power sustains organic revenue growth despite global inflationary pressures
- Commodity volatility and logistics costs impact gross margins across core segments
- Strategic brand concentration in Fabric and Home Care drives majority revenue
- Foreign exchange fluctuations negatively impact international earnings and dividend payout strength
- Market share competition from private labels increases during consumer spending slowdowns
| Net Income: 16.7b TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.12 > 0.02 and ΔFCF/TA -0.51 > 1.0 |
| NWC/Revenue: -11.82% < 20% (prev -11.69%; Δ -0.13% < -1%) |
| CFO/TA 0.15 > 3% & CFO 19.4b > Net Income 16.7b |
| Net Debt (25.7b) to EBITDA (23.2b): 1.11 < 3 |
| Current Ratio: 0.73 > 1.5 & < 3 |
| Outstanding Shares: last quarter (2.42b) vs 12m ago -1.36% < -2% |
| Gross Margin: 50.33% > 18% (prev 51.29%; Δ -0.96% > 0.5%) |
| Asset Turnover: 69.00% > 50% (prev 68.24%; Δ 0.76% > 0%) |
| Interest Coverage Ratio: 48.92 > 6 (EBIT TTM 20.2b / Interest Expense TTM 412.0m) |
| A: -0.08 (Total Current Assets 28.0b - Total Current Liabilities 38.2b) / Total Assets 128b |
| B: 1.05 (Retained Earnings 135b / Total Assets 128b) |
| C: 0.16 (EBIT TTM 20.2b / Avg Total Assets 126b) |
| D: 0.74 (Book Value of Equity 54.5b / Total Liabilities 73.6b) |
| Altman-Z'' = 4.77 = AA |
| DSRI: 1.00 (Receivables 6.32b/6.14b, Revenue 86.7b/83.9b) |
| GMI: 1.02 (GM 51.29% / 50.33%) |
| AQI: 0.96 (AQ_t 0.59 / AQ_t-1 0.62) |
| SGI: 1.03 (Revenue 86.7b / 83.9b) |
| TATA: -0.02 (NI 16.7b - CFO 19.4b) / TA 128b) |
| Beneish M = -3.01 (Cap -4..+1) = AA |
As of June 15, 2026, the stock is trading at USD 149.61 with a total of 5,037,403 shares traded.
Over the past week, the price has changed by +2.09%,
over one month by +4.83%,
over three months by -0.91% and
over the past year by -4.33%.
Procter & Gamble has received a consensus analysts rating of 3.96. Therefore, it is recommended to buy PG.
- StrongBuy: 9
- Buy: 5
- Hold: 10
- Sell: 0
- StrongSell: 0
| Analysts Target Price | 163.8 | 9.5% |
P/E Trailing = 21.6871
P/E Forward = 20.9205
P/S = 3.9834
P/B = 6.1337
P/EG = 4.1839
Revenue TTM = 86.7b USD
EBIT TTM = 20.2b USD
EBITDA TTM = 23.2b USD
Long Term Debt = 23.9b USD (from longTermDebt, last quarter)
Short Term Debt = 13.2b USD (from shortTermDebt, last quarter)
Debt = 38.0b USD (from shortLongTermDebtTotal, last quarter) + Leases 956.0m
Net Debt = 25.7b USD (calculated: Debt 38.0b - CCE 12.3b)
Enterprise Value = 371b USD (345b + Debt 38.0b - CCE 12.3b)
Interest Coverage Ratio = 48.92 (Ebit TTM 20.2b / Interest Expense TTM 412.0m)
EV/FCF = 24.69x (Enterprise Value 371b / FCF TTM 15.0b)
FCF Yield = 4.05% (FCF TTM 15.0b / Enterprise Value 371b)
FCF Margin = 17.33% (FCF TTM 15.0b / Revenue TTM 86.7b)
Net Margin = 19.22% (Net Income TTM 16.7b / Revenue TTM 86.7b)
Gross Margin = 50.33% ((Revenue TTM 86.7b - Cost of Revenue TTM 43.1b) / Revenue TTM)
Gross Margin QoQ = 49.51% (prev 51.22%)
Tobins Q-Ratio = 2.89 (Enterprise Value 371b / Total Assets 128b)
Interest Expense / Debt = 1.08% (Interest Expense 412.0m / Debt 38.0b)
Taxrate = 20.40% (4.28b / 21.0b)
NOPAT = 16.0b (EBIT 20.2b * (1 - 20.40%))
Current Ratio = 0.73 (Total Current Assets 28.0b / Total Current Liabilities 38.2b)
Debt / Equity = 0.70 (Debt 38.0b / totalStockholderEquity, last quarter 54.5b)
Debt / EBITDA = 1.11 (Net Debt 25.7b / EBITDA 23.2b)
Debt / FCF = 1.71 (Net Debt 25.7b / FCF TTM 15.0b)
Total Stockholder Equity = 53.3b (last 4 quarters mean from totalStockholderEquity)
RoA = 13.26% (Net Income 16.7b / Total Assets 128b)
RoE = 31.28% (Net Income TTM 16.7b / Total Stockholder Equity 53.3b)
RoCE = 26.13% (EBIT 20.2b / Capital Employed (Equity 53.3b + L.T.Debt 23.9b))
RoIC = 16.21% (NOPAT 16.0b / Invested Capital 99.0b)
WACC = 4.81% (E(345b)/V(383b) * Re(5.24%) + D(38.0b)/V(383b) * Rd(1.08%) * (1-Tc(0.20)))
Discount Rate = 5.24% (= CAPM, Blume Beta Adj.)
Shares (quarterly) Correlation: -82.22 | Cagr: -0.94%
[DCF] Terminal Value 75.44% ; FCFF base≈15.0b ; Y1≈15.1b ; Y5≈16.0b
[DCF] Fair Price = 95.78 (EV 249b - Net Debt 25.7b = Equity 223b / Shares 2.33b; r=8.35% [WACC [floored]]; 5y FCF grow 0.02% → 2.50% )
EPS Correlation: 91.61 | EPS CAGR: 5.13% | SUE: 0.82 | # QB: 0
Revenue Correlation: 87.26 | Revenue CAGR: 1.30% | SUE: 3.03 | # QB: 1
EPS next Quarter (2026-09-30): EPS=1.97 | Chg30d=+0.08% | Revisions=-75% | Analysts=14
EPS current Year (2026-06-30): EPS=6.90 | Chg30d=-0.04% | Revisions=-83% | GrowthEPS=+1.0% | GrowthRev=+3.4%
EPS next Year (2027-06-30): EPS=7.09 | Chg30d=-0.07% | Revisions=-83% | GrowthEPS=+2.7% | GrowthRev=+2.9%
[Analyst] Revisions Ratio: -83%